Paper Details
- Home
- Paper Details
Side effects associated with current and prospective antimigraine pharmacotherapies.
Author: González-HernándezAbimael, MaassenVanDenBrinkAntoinette, Marichal-CancinoBruno A, VillalónCarlos M
Original Abstract of the Article :
Label="INTRODUCTION" NlmCategory="BACKGROUND">Migraine is a neurovascular disorder. Current acute specific antimigraine pharmacotherapies target trigeminovascular 5-HT<sub>1B/1D</sub>, 5-HT<sub>1F</sub> and CGRP receptors but, unfortunately, they induce some cardiovascular and central side effects t...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1080/17425255.2018.1416097
データ提供:米国国立医学図書館(NLM)
Navigating the Migraine Desert: New Medications and Their Side Effects
Migraines are like desert storms, sudden and intense, causing debilitating pain that can disrupt lives. This research explores the landscape of migraine treatments, delving into the side effects of current medications and the potential benefits and risks of newer drugs. The authors meticulously examine the intricate mechanisms of migraine and the various medications that target specific receptors in the brain. They discuss the potential for new drugs to provide relief while minimizing the adverse effects of existing medications.
A New Oasis? The Promise of Gepants and CGRP Antibodies
The research highlights the potential of gepants and CGRP antibodies as promising new treatments for migraine. These medications offer a novel approach to migraine relief, targeting specific receptors in the brain that are implicated in the development of migraine headaches. The study underscores the need for ongoing research to assess their efficacy and safety, ensuring that these new treatments offer a true oasis in the migraine desert.
Navigating the Desert: Weighing the Risks and Benefits
While new medications offer hope for migraine sufferers, it's essential to remember that every medication comes with potential side effects. Understanding the risks and benefits of different treatment options is crucial for patients to make informed decisions about their health. It's like traversing a desert; we must be mindful of the challenges and opportunities that lie ahead, making choices that lead us towards well-being.
Dr.Camel's Conclusion
The research on migraine medications underscores the dynamic nature of medical science. As researchers, we are constantly searching for new ways to treat debilitating conditions, and the development of gepants and CGRP antibodies offers a glimmer of hope for migraine sufferers. It's a journey through the desert of medical knowledge, and we are committed to finding an oasis of effective treatments for all.
Date :
- Date Completed 2018-01-01
- Date Revised 2023-12-13
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.